RMD strong bullish for target 225"RMD has been in a strong bullish move over the last couple of days, targeting $225."
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
6.05EUR
822.89 MEUR
3.87 BEUR
145.73 M
About ResMed Inc.
Sector
Industry
CEO
Michael J. Farrell
Website
Headquarters
San Diego
Employees (FY)
10.14 K
Founded
1989
FIGI
BBG000JN7661
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
4/25/24 - $rmd imma buyer - vrockstar4/25/24 - vrockstar - first time i come across this ticker (i look at a lot), wow. great opex flex. software-ish margins, not expensive on various multiples i look at vs. growth looks awesome. chart yes. am i missing anything frens, i think i'm just buying this print b/c i like everything i see incl
RMD Long off Cup and Handle The white dotted line represents the Stocks average up trend, you can see the stock has squeezed down into an equal triangle (nor bullish or bearish) and looks bullish with that cup and handle right into the bottom. Looking for a safe gain to major resistance at $34.18 Daily RSI shows above 50 after
ResMed: Margin Of Safety Gives Investors A Good Night's SleepResMed Inc. is a leader in digital health and cloud-connected medical devices. ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea comb
RMD - Bullish Price ActionResMed Inc. (RMD) - Bullish Price Action Analysis
Date: 28 Dec 2023
Overview: ResMed Inc. (RMD) is currently exhibiting signs of bullish price action. This analysis provides a potential trading outlook based on the stock's recent market behavior and technical analysis.
Current Market Observations
RMD buyBase on trendline, this counter still in bullish condition. It just rebound at MA200 line. Target TP1 at price USD224
$RMD with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $RMD after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 50%.
ResMed - low beta stock with solid balance sheetWe like low beta stocks, and ResMed is one of them.
Solid balance sheet and high profit margin.
Not cheap based on P/E, but justified by high RoE and high margins.
Resmed Australia SSI Live Trading Series
Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's
Focus: Worldwide
By Sun Storm Investment Research & NexGen Wealth Management Service
A Profit & Solutions Strategy & Research
Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | B
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Resmed Inc. stocks are traded under the ticker RME.
We've gathered analysts' opinions on Resmed Inc. future price: according to them, RME price has a max estimate of 228.12 EUR and a min estimate of 166.40 EUR. Watch RME chart and read a more detailed Resmed Inc. stock forecast: see what analysts think of Resmed Inc. and suggest that you do with its stocks.
Yes, you can track Resmed Inc. financials in yearly and quarterly reports right on TradingView.
Resmed Inc. is going to release the next earnings report on Aug 1, 2024. Keep track of upcoming events with our Earnings Calendar.
RME earnings for the last quarter are 1.97 EUR per share, whereas the estimation was 1.79 EUR resulting in a 10.51% surprise. The estimated earnings for the next quarter are 1.91 EUR per share. See more details about Resmed Inc. earnings.
Resmed Inc. revenue for the last quarter amounts to 1.11 B EUR despite the estimated figure of 1.09 B EUR. In the next quarter revenue is expected to reach 1.12 B EUR.
RME net income for the last quarter is 278.49 M EUR, while the quarter before that showed 189.17 M EUR of net income which accounts for 47.21% change. Track more Resmed Inc. financial stats to get the full picture.
Yes, RME dividends are paid quarterly. The last dividend per share was 0.45 EUR. As of today, Dividend Yield (TTM)% is 0.85%. Tracking Resmed Inc. dividends might help you take more informed decisions.
Resmed Inc. dividend yield was 0.81% in 2023, and payout ratio reached 28.91%. The year before the numbers were 0.80% and 31.69% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 17, 2024, the company has 10.14 K employees. See our rating of the largest employees — is Resmed Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Resmed Inc. EBITDA is 1.40 B EUR, and current EBITDA margin is 31.93%. See more stats in Resmed Inc. financial statements.
Like other stocks, RME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Resmed Inc. stock right from TradingView charts — choose your broker and connect to your account.